Vertex presents positive data for ALYFTREK in young cystic fibrosis patients Jun 5, 2026 12:05PM
Vertex gets FDA acceptance for IgA nephropathy drug application Jun 1, 2026 08:01AM
Truist Securities Assumes Vertex (VRTX) at Buy May 27, 2026 01:02AM
BMO Capital Reiterates Market Perform Rating on Vertex (VRTX), 'positive steps' May 8, 2026 08:59AM
Vertex secures German reimbursement for CASGEVY gene therapy May 6, 2026 07:01AM
View Older Stories

May 5, 2026 09:26AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print
May 5, 2026 07:50AM Vertex (VRTX) PT Lowered to $436 at Canaccord
May 5, 2026 06:06AM Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)
May 5, 2026 05:59AM Vertex (VRTX) PT Lowered to $572 at Bernstein SocGen Group
May 4, 2026 04:03PM Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance
Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews
Apr 23, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
Apr 19, 2026 10:00AM These are the best biotech stocks to own in 2026: BofA
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 10, 2026 08:33AM Vertex (VRTX) PT Lowered to $541 at RBC Capital
Apr 7, 2026 08:05AM Halozyme licenses drug delivery technology to Vertex for $15 million
Mar 30, 2026 08:26AM BMO Capital on Vertex (VRTX): 'Ivacaftor Related Label Updates Unlikely to Impact CF Franchise Strength'
Mar 27, 2026 03:37PM BMO Capital on Vertex (VRTX): label updates weigh on shares, but risk is limited
Mar 21, 2026 01:55PM New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Mar 19, 2026 08:55AM RBC Capital on Vertex (VRTX): 'Recent Weakness Creates Buying Opportunity'
Mar 19, 2026 05:27AM Vertex (VRTX) PT Raised to $520 at Argus
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Mar 10, 2026 09:51AM Vertex (VRTX) PT Raised to $525 at Truist Securities
Mar 10, 2026 09:33AM Stifel Reiterates Hold Rating on Vertex (VRTX)
Mar 10, 2026 08:27AM Vertex (VRTX) PT Raised to $641 at H.C. Wainwright
Mar 10, 2026 08:02AM Bernstein: 'We continue to recommend Vertex (VRTX) and see no reason to take profits'
Mar 10, 2026 05:38AM Jefferies Starts Amgen (AMGN) at Hold
Mar 10, 2026 05:38AM Jefferies Starts Vertex (VRTX) at Buy
Mar 10, 2026 05:38AM Jefferies Starts Gilead Sciences (GILD) at Buy
Mar 10, 2026 05:09AM Vertex (VRTX) PT Raised to $600 at Oppenheimer
Mar 10, 2026 04:56AM Vertex (VRTX) PT Raised to $585 at Citi
Mar 9, 2026 05:35PM Wolfe Research Reiterates Outperform Rating on Vertex (VRTX) following Ph3
Mar 9, 2026 05:07PM BMO Capital Reiterates Outperform Rating on Vertex (VRTX) amid interim RAINIER data
Mar 9, 2026 04:44PM After-hours movers: Hewlett Packard Enterprise, Yext, Vertex Pharma
Mar 2, 2026 09:28AM Vertex (VRTX) PT Raised to $600 at BMO Capital
Feb 13, 2026 09:03AM Vertex (VRTX) PT Raised to $590 at Cantor Fitzgerald
Feb 13, 2026 06:43AM Oppenheimer Upgrades Vertex (VRTX) to Outperform
Feb 12, 2026 04:11PM Vertex Pharma (VRTX) Misses Q4 EPS by 5c; offers guidance
Feb 10, 2026 07:48AM Bernstein SocGen Group Reiterates Outperform Rating on Vertex (VRTX)
Jan 28, 2026 06:20AM Barclays Starts Vertex (VRTX) at Overweight, 'bullish into 2026 readouts'
Jan 23, 2026 04:44AM Vertex (VRTX) PT Raised to $530 at Evercore ISI
Jan 22, 2026 05:05AM RBC Capital Upgrades Vertex (VRTX) to Outperform
Jan 12, 2026 06:18AM Bernstein SocGen Group Upgrades Vertex (VRTX) to Outperform
Jan 12, 2026 04:07AM Vertex reports drug pipeline progress ahead of investor meetings
Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC
Jan 6, 2026 05:35AM Wolfe Research Upgrades Vertex (VRTX) to Outperform
Jan 2, 2026 10:52AM BofA unveils its top 10 U.S. ideas for Q1 2026
Jan 2, 2026 08:43AM BofA: 'our Top 10 Ideas include nine Buys and one Underperform across nine industries'
Dec 18, 2025 06:24AM BofA: 'Top SMid Biotech Picks Argenx, KalVista, Ocular, and Vertex'
Dec 12, 2025 10:17AM BMO Capital Reiterates Outperform Rating on Vertex (VRTX)
Dec 8, 2025 02:54AM Vertex shares new CASGEVY data for children ages 5-11 at medical meeting
Dec 3, 2025 03:51AM Morgan Stanley Upgrades Vertex (VRTX) to Overweight
Nov 12, 2025 04:14PM Scotiabank Starts Vertex (VRTX) at Sector Outperform
Nov 11, 2025 10:50AM Vertex In 'advanced' Talks With Large Pbm On Journavx Coverage - Bloomberg
Nov 10, 2025 10:01AM Stifel Reiterates Hold Rating on Vertex (VRTX)
View Older Stories